| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.8M | -55.8% |
| R&D Expense | $71.8M | -6.5% |
| SG&A Expense | $41.7M | -0.1% |
| Operating Income | -$110.7M | +1.7% |
| Net Income | -$97.3M | +11.4% |
| EPS (Basic) | -$1.59 | +34.8% |
| EPS (Diluted) | -$1.59 | +34.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.6M | -27.2% |
| Current Assets | $242.2M | +16.7% |
| Total Assets | $257.7M | +13.7% |
| Current Liabilities | $13.7M | -18.2% |
| Total Liabilities | $22.5M | -18.9% |
| Stockholders' Equity | $235.2M | +18.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$91.0M | +6.3% |
| Capital Expenditures | $508K | -74.1% |
| Investing Cash Flow | -$36.7M | -395.6% |
| Financing Cash Flow | $118.1M | +40.1% |
| Free Cash Flow | -$91.5M | +7.6% |